| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 24,411 | 40,580 | 48,534 | 53,407 |
| Short-term investments | 122,273 | 114,375 | 88,609 | 54,972 |
| Accounts receivable, net | 49,945 | 51,763 | 45,925 | 39,907 |
| Inventories | 11,652 | 11,506 | 13,303 | 10,423 |
| Prepaid and other current assets | 25,746 | 21,942 | 18,556 | 16,684 |
| Total current assets | 234,027 | 240,166 | 214,927 | 175,393 |
| Property and equipment, net | NaN | NaN | 54 | 57 |
| Intangible assets, net | 24,160 | 24,748 | 25,336 | 25,924 |
| Deferred income tax asset | 243,279 | 245,852 | NaN | NaN |
| Operating lease right-of-use assets | 785 | 920 | 1,050 | 1,178 |
| Other assets | 2,357 | 1,908 | 1,167 | 4,184 |
| Total assets | 504,608 | 513,594 | 242,534 | 206,736 |
| Accounts payable | 4,486 | 7,191 | 3,846 | 7,290 |
| Accrued compensation | 6,009 | 11,914 | 10,065 | 7,897 |
| Deferred revenue | NaN | NaN | 1,355 | 1,355 |
| Accrued research and development | 5,742 | 5,524 | 4,816 | 4,121 |
| Acquisition-related liabilities | 5,000 | 5,000 | 5,000 | 5,000 |
| Revenue reserves and refund liability | 28,080 | 27,716 | 30,020 | 29,502 |
| Loans payable, net, current portion | 29,865 | 29,812 | 29,761 | 22,361 |
| Other current liabilities | NaN | 11,466 | NaN | NaN |
| Other accrued liabilities | 9,674 | NaN | 8,943 | 8,593 |
| Lease liabilities, current portion | 636 | 614 | 594 | 517 |
| Total current liabilities | 89,492 | 99,237 | 94,400 | 86,636 |
| Acquisition-related liabilities | NaN | 0 | NaN | NaN |
| Long-term portion of lease liabilities | 228 | 395 | 556 | 714 |
| Long-term portion of loans payable, net | 14,991 | 22,482 | 29,969 | 37,452 |
| Other long-term liabilities | NaN | 0 | NaN | NaN |
| Total liabilities | 104,711 | 122,114 | 124,925 | 124,802 |
| Common stock | 18 | 18 | 18 | 18 |
| Additional paid-in capital | 1,414,394 | 1,414,322 | 1,408,601 | 1,400,916 |
| Accumulated other comprehensive (loss) income | -128 | 181 | 96 | 6 |
| Accumulated deficit | -1,014,387 | -1,023,041 | -1,291,106 | -1,319,006 |
| Total stockholders equity | 399,897 | 391,480 | 117,609 | 81,934 |
| Total liabilities and stockholders equity | 504,608 | 513,594 | 242,534 | 206,736 |
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)